Welcome to Medications.com
 

Atypical antipsychotic drugs symptoms and conditions

Here are side effects posted by other members, that mention atypical antipsychotic drugs.
Click on a listing to see the full text of the user's posting, and any replies.
50 Side Effects posted for atypical antipsychotic drugs

July 22th
2008
10:23 AM

I'm trying to wean myself off Geodon and I had a minor, panic attack,. My doctor won't help me because she said I need to see a psychiatrist but I can't afford to see one. Does anyone know how long the side effect last when you get off Geodon. I am a single parent and have a job I need to function at so any advice will help. I have ,anxiety, all the time the doc had to prescribe some anti-anxiety medicine which I never had anxiety like that before. My symptoms on the medication is sleeplessness, restlessness, loss of appetite, can quit moving, racing thoughts, depression.

-- By ldypo29 | Reply | (7) replies | Private Message me


 

Medications contributing to atypical antipsychotic drugs

Geodon (1)  

Related Articles

FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs
FDA Proposes New Rule to Automate Drug Registration and Listing
FDA Acts to Improve Drug Safety and Quality
FDA Announces New Measures to Protect Americans from Counterfeit Drugs
FDA Issues Warning Letters to Bayer HealthCare for Illegally Marketing Two Unapproved Drugs
FDA Continues To Tackle Unapproved Drugs
FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India
FDA Finds Consumers Continue to Buy Potentially Risky Drugs Over the Internet
FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs
FDA Proposes New Rule to Provide Updated Information on the Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding
FDA Announces New Prescription Drug Information Format to Improve Patient Safety
FDA Proposes Rules Overhaul to Expand Availability of Experimental Drugs
Federal Agents Seize more than $24 Million in Unapproved New Drugs
FDA Grants Tentative Approval for 50th and 51st Anti-Retroviral Drugs Under President's AIDS Relief Plan
FDA Reinforces Commitment to Drug Safety
FDA Obtains Permanent Injunction Barring Two Companies from Manufacturing and Distributing Unapproved Drugs
New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
FDA Alerts Health Care Providers to Risk of Suicidal Thoughts and Behavior with Antiepileptic Medications
FDA Takes Action to Halt Marketing of Unapproved Ergotamine Companies Ordered to Cease Manufacturing and Distribution of Illegal Drugs to Treat Migraine Headaches
FDA Proposes New Measures to Strengthen Drug Safety Under PDUFA Reauthorized User Fee Program
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea